Artificial intelligence is changing healthcare from how we diagnose diseases, model drug development, and predict response to therapies. The Boston Business Journal names Scipher Medicine as one of the companies leading the way in this endeavor due to Prism’s unique ability to understand various autoimmune diseases to understand response and our ability to gather data to further realize the potential of AI.
